ABSTRACT
The Supplemental Appropriations Act of 1987 (Public Law 100-71, Section 503) outlined the general provisions for drug testing programs within the federal sector, and directed the Secretary of the Department of Health and Human Services (DHHS) to set comprehensive standards for all aspects of laboratory drug testing. The authority to develop and promulgate these standards was delegated to the National Institute on Drug Abuse (NIDA), an institute within the Alcohol, Drug Abuse and Mental Health Administration (ADAMHA). Following the ADAMHA Reorganization Act (Public Law No. 102-321) in 1992, the authority for this oversight now resides within the Center for Substance Abuse Prevention (CSAP), Substance Abuse and Mental Health Services Administration (SAMHSA). The Division of Workplace Programs (DWP) in CSAP, SAMHSA, administers and directs the National Laboratory Certification Program (NLCP), which certifies laboratories to perform drug testing in accordance with the “Mandatory Guidelines for Federal Workplace Drug Testing Programs” (Guidelines). These Guidelines were first published by the Secretary of HHS in the
Federal Register
on April 11, 1988,
and were revised and published in the
Federal Register
on June 9, 1994
and again on November 13, 1998.
